Search results
Results from the WOW.Com Content Network
The European Coalition for Just and Effective Drug Policies (ENCOD), originally European NGO Council On Drugs and development, [1] is a network of European non-governmental organisations and citizens [2] concerned with the impact of current international drug policies on the lives of the most affected sectors in Europe and the Global South.
Until 1916 drug use was hardly controlled, and widely available opium and coca preparations commonplace. [1]: 13–14 Between 1916 and 1928 concerns about the use of these drugs by troops on leave from the First World War and then by people associated with the London criminal society gave rise to some controls being implemented. [1]
Drug policies are usually aimed at combatting drug addiction or dependence addressing both demand and supply of drugs, as well as mitigating the harm of drug use, and providing medical assistance and treatment. Demand reduction measures include voluntary treatment, rehabilitation, substitution therapy, overdose management, alternatives to ...
The Misuse of Drugs Act 1971 [1] (c. 38) is an act of the Parliament of the United Kingdom.It represents action in line with treaty commitments under the Single Convention on Narcotic Drugs, [2] the Convention on Psychotropic Substances, [3] and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
Drug control law in the United Kingdom (1 C, 12 P) Pages in category "Drug policy of the United Kingdom" The following 8 pages are in this category, out of 8 total.
Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system.It embraces drugs (both brand name and generic), biologics (products derived from living sources, as opposed to chemical compositions), vaccines and natural health products.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Or, alternatively, the company may alter the list price. Outcome-based schemes take place when a company agrees to a later increase in price, or a rebate, once the value of the drug has been proven. Alternatively risk-sharing agreements can be put in place whereby outcomes are measured and price adjustments take place accordingly.